These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36567408)

  • 1. COVID19 vaccine in myasthenia gravis patients: safety and possible predictors of disease exacerbation.
    Trinchillo A; Esposito M; Habetswallner F; Tuccillo F; De Martino BM
    Neurol Sci; 2023 Feb; 44(2):447-450. PubMed ID: 36567408
    [No Abstract]   [Full Text] [Related]  

  • 2. COVID-19 vaccination in myasthenia gravis: safe, but predictors of disease exacerbation yet to be determined.
    Kim S; Eun MY; Seok HY
    Neurol Sci; 2023 May; 44(5):1503-1504. PubMed ID: 36808584
    [No Abstract]   [Full Text] [Related]  

  • 3. BNT162b2 mRNA COVID-19 vaccine three-dose safety and risk of COVID-19 in patients with myasthenia gravis during the alpha, delta, and omicron waves.
    Doron A; Piura Y; Vigiser I; Kolb H; Regev K; Nesher N; Karni A
    J Neurol; 2022 Dec; 269(12):6193-6201. PubMed ID: 35907046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of mRNA COVID-19 vaccines in patients with well-controlled myasthenia gravis.
    Gamez J; Gamez A; Carmona F
    Muscle Nerve; 2022 Nov; 66(5):612-617. PubMed ID: 36029224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of COVID-19 vaccine in patients with myasthenia gravis: a self-controlled case series study.
    Ruan Z; Huan X; Su Y; Tang YL; Meng DD; Ren DL; Li CH; Hao SJ; Zhao CB; Luo SS; Li ZY; Chang T
    Front Immunol; 2023; 14():1141983. PubMed ID: 37223097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An observational study on the safety of COVID-19 vaccination in patients with myasthenia gravis.
    Wang HY; Qiu L; Ou CY; Lin ZQ; Huang ZD; Chen P; Ma Q; Lu YR; Ran H; Liu WB
    Neurol Sci; 2023 Jul; 44(7):2239-2245. PubMed ID: 37160544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cogan's sign in a patient with suspected post-COVID-19 vaccine-associated myasthenia gravis.
    Tavares-Júnior JWL; Sobreira-Neto MA; Braga-Neto P
    Rev Soc Bras Med Trop; 2023; 56():e0007. PubMed ID: 37283341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccines and myasthenia gravis: a comprehensive review and retrospective study of SARS-CoV-2 vaccination in a large cohort of myasthenic patients.
    Sansone G; Bonifati DM
    J Neurol; 2022 Aug; 269(8):3965-3981. PubMed ID: 35503373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flare of myasthenia gravis induced by COVID-19 vaccines.
    Ishizuchi K; Takizawa T; Sekiguchi K; Motegi H; Oyama M; Nakahara J; Suzuki S
    J Neurol Sci; 2022 May; 436():120225. PubMed ID: 35290838
    [No Abstract]   [Full Text] [Related]  

  • 10. The safety of COVID-19 vaccines in patients with myasthenia gravis: A scoping review.
    Peng S; Tian Y; Meng L; Fang R; Chang W; Yang Y; Li S; Shen Q; Ni J; Zhu W
    Front Immunol; 2022; 13():1103020. PubMed ID: 36618419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of SARS-CoV-2 vaccines in patients with myasthenia gravis: a meta-analysis.
    Zheng Q; Cheng Y; Song C; Feng Z; Xu Z
    Neurol Sci; 2023 Sep; 44(9):2999-3003. PubMed ID: 37243794
    [No Abstract]   [Full Text] [Related]  

  • 12. Electronic health record derived-impact of COVID-19 on myasthenia gravis.
    Roy B; Kovvuru S; Nalleballe K; Onteddu SR; Nowak RJ
    J Neurol Sci; 2021 Apr; 423():117362. PubMed ID: 33639420
    [No Abstract]   [Full Text] [Related]  

  • 13. A Case of COVID-19 Vaccine Associated New Diagnosis Myasthenia Gravis.
    Chavez A; Pougnier C
    J Prim Care Community Health; 2021; 12():21501327211051933. PubMed ID: 34709075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to letter to the editor regarding
    Maher DI; Hogarty D; Ben Artsi E
    Orbit; 2022 Oct; 41(5):662-663. PubMed ID: 35686598
    [No Abstract]   [Full Text] [Related]  

  • 15. Safety and Immunogenicity of Additional SARS-CoV-2 Vaccinations in a Patient With Myasthenia Gravis on Mycophenolate: A Case Report.
    McNeish BL; Colletti RB; Hehir MK
    J Clin Neuromuscul Dis; 2022 Dec; 24(2):113-114. PubMed ID: 36409346
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety and tolerability of SARS-Cov-2 vaccination in patients with myasthenia gravis: A multicenter experience.
    Farina A; Falso S; Cornacchini S; Spagni G; Monte G; Mariottini A; Massacesi L; Barilaro A; Evoli A; Damato V
    Eur J Neurol; 2022 Aug; 29(8):2505-2510. PubMed ID: 35390184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. To Be or Not To Be Vaccinated: That Is a Question in Myasthenia Gravis.
    Zhou Q; Zhou R; Yang H; Yang H
    Front Immunol; 2021; 12():733418. PubMed ID: 34603311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early safety and tolerability profile of the BNT162b2 COVID-19 vaccine in myasthenia gravis.
    Lotan I; Hellmann MA; Friedman Y; Stiebel-Kalish H; Steiner I; Wilf-Yarkoni A
    Neuromuscul Disord; 2022 Mar; 32(3):230-235. PubMed ID: 35227552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 vaccination and new-onset myasthenia gravis: A report of 7 cases and review of the literature.
    Ramdas S; Hum RM; Price A; Paul A; Bland J; Burke G; Farrugia M; Palace J; Storrie A; Ho P; Standing E; Lilleker JB; Jungbluth H
    Neuromuscul Disord; 2022 Oct; 32(10):785-789. PubMed ID: 36130855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New-onset myasthenia gravis after mRNA SARS-CoV-2 vaccination: a case series.
    Fanella G; Baiata C; Candeloro E; Toscano G; Colnaghi S; Mauri M; Cariddi LP; Rebecchi V; Solazzo F; Banfi P; Piatti M; Ferrarese C; Versino M
    Neurol Sci; 2022 Oct; 43(10):5799-5802. PubMed ID: 35870026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.